Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
1-Year Return 26.64%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
-2.2%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$153B
AUM Growth
-$8.09B
Cap. Flow
-$1.98B
Cap. Flow %
-1.3%
Top 10 Hldgs %
25.93%
Holding
2,638
New
46
Increased
1,454
Reduced
934
Closed
79

Sector Composition

1 Technology 31.61%
2 Healthcare 19.69%
3 Financials 10.19%
4 Industrials 9.75%
5 Consumer Discretionary 9.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RIVN icon
151
Rivian
RIVN
$16.6B
$237M 0.16%
9,764,750
+1,739,150
+22% +$42.2M
TRU icon
152
TransUnion
TRU
$17.3B
$228M 0.15%
3,176,494
+3,629
+0.1% +$261K
TSLA icon
153
Tesla
TSLA
$1.09T
$227M 0.15%
908,602
-11,252
-1% -$2.82M
AKRO icon
154
Akero Therapeutics
AKRO
$3.52B
$227M 0.15%
4,486,726
+61,607
+1% +$3.12M
RRX icon
155
Regal Rexnord
RRX
$9.78B
$225M 0.15%
1,571,567
+412
+0% +$58.9K
MPC icon
156
Marathon Petroleum
MPC
$54.4B
$222M 0.15%
1,467,850
-282,885
-16% -$42.8M
CRH icon
157
CRH
CRH
$74.9B
$222M 0.15%
+3,996,232
New +$222M
FTV icon
158
Fortive
FTV
$16.1B
$220M 0.14%
2,962,858
+1,924,852
+185% +$143M
VICI icon
159
VICI Properties
VICI
$35.7B
$218M 0.14%
7,501,446
+8,727
+0.1% +$254K
LNTH icon
160
Lantheus
LNTH
$3.66B
$215M 0.14%
3,090,150
+2,179,640
+239% +$151M
CASY icon
161
Casey's General Stores
CASY
$18.5B
$210M 0.14%
773,905
-19,923
-3% -$5.41M
OXY icon
162
Occidental Petroleum
OXY
$45.9B
$210M 0.14%
3,237,754
-26,701
-0.8% -$1.73M
JNJ icon
163
Johnson & Johnson
JNJ
$431B
$208M 0.14%
1,333,272
-24,826
-2% -$3.87M
FIS icon
164
Fidelity National Information Services
FIS
$35.9B
$207M 0.14%
3,750,817
-173,252
-4% -$9.58M
GIL icon
165
Gildan
GIL
$8.21B
$202M 0.13%
7,212,254
+3,331
+0% +$93.3K
AVGO icon
166
Broadcom
AVGO
$1.44T
$202M 0.13%
2,430,810
+1,793,170
+281% +$149M
SRE icon
167
Sempra
SRE
$53.6B
$201M 0.13%
2,954,784
+142,730
+5% +$9.71M
EQIX icon
168
Equinix
EQIX
$75.2B
$198M 0.13%
273,055
+175,682
+180% +$128M
UTHR icon
169
United Therapeutics
UTHR
$17.2B
$198M 0.13%
876,568
-2,276
-0.3% -$514K
RBA icon
170
RB Global
RBA
$21.5B
$198M 0.13%
3,165,137
+6,892
+0.2% +$431K
ICLR icon
171
Icon
ICLR
$13.7B
$197M 0.13%
800,937
+2,563
+0.3% +$631K
BLKB icon
172
Blackbaud
BLKB
$3.22B
$194M 0.13%
2,760,383
-3,391
-0.1% -$238K
NBIX icon
173
Neurocrine Biosciences
NBIX
$13.9B
$193M 0.13%
1,717,054
-191,790
-10% -$21.6M
WAT icon
174
Waters Corp
WAT
$17.8B
$193M 0.13%
703,858
+123,377
+21% +$33.8M
ELV icon
175
Elevance Health
ELV
$69.4B
$193M 0.13%
442,418
-9,053
-2% -$3.94M